SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Tikvah Therapeutics Enters an Exclusive Licensing Agreement With Apkarian Technologies Related to Agents for Treatment of Pain and Pain-Related Indications